GlassScriptPhysician profile
Audra Adkinson
NPI 1801460100
$4,277.69
in general payments reported to CMS, 2019-2025
37 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $925 · 2023: $1,305 · 2024: $780 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,352.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $585.14 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $467.08 | 2022-2025 | |
| Abbvie INC. | $317.65 | 2022-2025 | Venclexta |
| Ucb, INC. | $302.85 | 2025 | Bimzelx |
| Glaxosmithkline, LLC. | $251.28 | 2024-2025 | Benlysta, Ojjaara |
| Daiichi Sankyo INC. | $244.07 | 2022-2024 | Enhertu, Injectafer |
| Merck Sharp & Dohme LLC | $219.21 | 2022-2024 | Keytruda, Lenvima, Lynparza |
| Janssen Biotech, INC. | $219.04 | 2022-2025 | Tremfya, Rybrevant, Erleada |
| Incyte Corporation | $169.14 | 2022-2024 | Jakafi |
| Seagen INC. | $121.85 | 2022-2023 | Adcetris |
| Celgene Corporation | $116.29 | 2023 | Reblozyl, Opdualag |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Gilead Sciences, INC. | $99.26 | 2024 | |
| Aveo Pharmaceuticals, INC. | $92.24 | 2023-2024 | Fotivda |
| Mallinckrodt Hospital Products INC. | $90.70 | 2025 | Acthar |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $88.29 | 2022-2024 | Jaypirca, Verzenio |
| Pharmacosmos Therapeutics INC. | $88.00 | 2022-2024 | Monoferric |
| Genzyme Corporation | $64.52 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.21 | 2024 | Alunbrig, Iclusig |
| Taiho Oncology, INC. | $58.13 | 2023-2024 | |
| Rigel Pharmaceuticals, INC. | $56.83 | 2022 | |
| Amgen INC. | $53.67 | 2022-2025 | Otezla, Tavneos |
| E.R. Squibb & Sons, L.L.C. | $51.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $46.11 | 2025 | Saphnelo |
| Radius Health, INC. | $41.48 | 2025 | Tymlos |
| Puma Biotechnology, INC. | $34.56 | 2022-2023 | |
| Emmaus Medical, INC. | $33.88 | 2022 | |
| Cti Biopharma Corp. | $31.59 | 2023 | Vonjo |
| Eisai INC. | $24.35 | 2023 | |
| Sobi, INC | $21.31 | 2022 | |
| Genentech USA, INC. | $20.73 | 2022-2023 | Venclexta |
| Heron Therapeutics, INC. | $20.51 | 2023 | Cinvanti |
| Boston Scientific Corporation | $19.99 | 2024 | |
| Kyowa Kirin, INC. | $18.38 | 2023 | Poteligeo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.17 | 2025 | |
| Myriad Genetic Laboratories, INC. | $16.71 | 2023 | Myrisk |
| Macrogenics, INC. | $14.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Adkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.